Relevance of the 21-gene expression assay in male breast cancer: A systematic review and meta-analysis
Open Access
- 28 April 2022
- journal article
- review article
- Published by Elsevier in The Breast
- Vol. 64, 41-46
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Research Institute
This publication has 42 references indexed in Scilit:
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013Annals of Oncology, 2013
- Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health StudyLaboratory Investigation, 2011
- Androgen receptor molecular biology and potential targets in prostate cancerTherapeutic Advances in Urology, 2010
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast CancerJournal of Clinical Oncology, 2010
- Multidisciplinary Meeting on Male Breast Cancer: Summary and Research RecommendationsJournal of Clinical Oncology, 2010
- Male Breast Cancer: A Population-Based Comparison With Female Breast CancerJournal of Clinical Oncology, 2010
- Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cellsBreast Cancer Research and Treatment, 2009
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic SubtypesJournal of Clinical Oncology, 2009
- Male breast cancerThe Lancet, 2006
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004